Quantitative RT-PCR analysis demonstrated lower KRAS G12D mRNA expression in these three PDTO compared to KRAS G12D/A*11:01-expressing pancreatic cancer cell lines known to be recognized by the KRAS G12D/A*11:01-restricted TCR (Fig. 6a) [14]. Here, KRAS is linked to pancreatic neoplasm.